Pathophysiology, Diagnosis, and Management of the No-Reflow PhenomenonJoseph Allencherril, Yochai Birnbaum, Hani Jneid et al.|Cardiovascular Drugs and Therapy|2019Cited by 72
Dual Antiplatelet Therapy: A Concise Review for CliniciansHafeez Ul Hassan Virk, Chayakrit Krittanawong, Johao Escobar et al.|Life|2023Cited by 45
The CHA 2 DS 2 -VASc score: Not as simple as it seemsXiaoming Jia, Yochai Birnbaum, Glenn N. Levine|International Journal of Cardiology|2018Cited by 15
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?Joseph Allencherril, Yochai Birnbaum, Mahboob Alam et al.|Journal of Cardiovascular Pharmacology and Therapeutics|2018Cited by 11
Pharmaceutical and clinical implications of proton pump inhibitors with dual antiplatelet therapies: a systematic reviewJacob J. Gries, Chayakrit Krittanawong, Umair Khalid et al.|npj gut and liver.|2025Cited by 6